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Abstract
Genotyping mice by DNA based methods is both laborious and costly. As an alternative, we systematically examined
fluorescent proteins expressed in the lens as transgenic markers for mice. A set of eye markers has been selected such that
double and triple transgenic animals can be visually identified and that fluorescence intensity in the eyes can be used to
distinguish heterozygous from homozygous mice. Taken together, these eye markers dramatically reduce the time and cost
of genotyping transgenics and empower analysis of genetic interaction.
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Introduction
Transgenic and knockout studies in mice and other mammals
are critical in understanding gene function as well as modeling
human diseases. However, isolation of genomic DNA and
identification of genetically modified animals using Southern
blotting or PCR-based genotyping can be costly and time
consuming especially when crosses involve multiple genetic
alterations. Visible transgenic markers, such as eye color and
fluorescent protein markers, are commonly used in invertebrate
and some vertebrate model systems to identify transgenic animals
[1,2,3]. Although ubiquitous fluorescent proteins have been used
successfully in mice to label tissues and cells [4,5], their utility as
transgenic markers is limited as they can interfere with studies
using fluorescent protein fusions or lineage markers [6,7]. A more
efficient marker system to facilitate genotyping and reduce animal
costs is extremely desirable.
Results
We sought to develop a set of fluorescent protein markers that
could be easily employed and widely applicable for genetic studies
in mice and other mammals. We generated marker constructs
containing nine different fluorescent proteins ranging from blue to
far-red spectral emissions [8] under the control of the mouse aA-
crystallin promoter which is highly expressed specifically in lens
epithelial cells [9]. To test these fluorescent eye markers, we
transfected them into mouse lens epithelial a-TN4 cells [10] (Fig. 1)
and visualized them by fluorescent microscopy. Based on overall
brightness and spectral separation, five marker proteins (mCFP,
EGFP, mOrange, tdTomato and mPlum) [11,12,13] were chosen
for in vivo testing in transgenic mice. We generated transgenic mice
by pronuclear injection of fluorescent eye marker DNA with
unrelated transgenes (see Methods). The unrelated transgenes
included piggyBac (PB) transposon mutator constructs and PB
transposase (PBase or PBaseER) constructs for somatic forward
genetic screens [14]. It has been previously reported that when two
linear DNA fragments are co-injected in the generation of
transgenic mice, they often co-integrate into the genome as a
transgene concatamer containing both transgenes [5,15,16,17,18].
Thus, when present in the same transgene concatamer, the
fluorescent eye marker can reliably indicate the presence of the
unrelated transgene. A total of 32 founder mice carrying the
fluorescent eye markers were selected after PCR genotyping and
backcrossed to the FVB/NJ background. All of these founders
transmitted the eye marker to their offspring. To determine the
visibility of fluorescent proteins in the eye, we examined transgenic
mice under a portable dual fluorescent flashlight. Twenty-seven
lines out of the 32 (84%) showed visible fluorescence after
excitation under the portable flashlight (Fig. 2A). These eye
markers were also visible under a portable longwave UV lamp as
described previously with ubiquitous fluorescent markers [4,5].
Fluorescence intensity varied between different lines with the
dimmest being visible only after excitation in a dark room and the
brightest lines being visible in room light even without excitation
(Fig. 2B). We also crossed some lines onto black and agouti
backgrounds to analyze how pigment affects visualization of the
fluorescent eye markers. The presence of pigment reduced the
intensity of fluorescence (Fig. 2B). Nevertheless, the high and
medium EGFP and tdTomato lines are still easily visible in both
agouti and black backgrounds even when the room light is on.
However, the low expressing reporter lines are faint in pigmented
mice, although they are still detectable in a dark room. Thus, these
reporters can be used for both pigmented and non-pigmented
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generations (.25 generations in some lines) and we have not
observed inactivation of the fluorescent markers over time. Thus
eye marker fluorescence can be consistently followed from one
generation to the next.
We next addressed the question of whether the eye markers
could be used to reliably identify the presence of the unrelated
transgene with which they were co-injected. Of the 27 transgenic
founders with visible fluorescent eye markers, 21 (78%) were
shown by PCR genotyping to also carry the unrelated transgene.
To establish co-integration of the eye markers and the unrelated
transgene, we studied their segregation in the F1 and subsequent
generations. Animals with visible fluorescence in the eye, as well
as littermates with no fluorescence, were analyzed by PCR for the
presence of the unrelated transgene. It was assumed that co-
integration at a single site occurred if all animals with visible
fluorescence in the eye were positive for the unrelated transgene
while all animals with no fluorescence in the eye were negative
for the unrelated transgene. Of the 21 lines analyzed, 20 (95%)
showed co-segregation of the transgene and its eye marker (for
example see Fig. 3A). In all of the transgenic lines where co-
segregation was observed, the transgenes have segregated
together in all subsequent crosses (.200) indicating that mice
can be efficiently genotyped for the unrelated transgene by
screening for the presence of the fluorescent eye marker. In one
instance the transgene segregated from the marker in the F1
generation. Thus, in some situations, it may be beneficial to
combine the two onto a single construct. To further confirm co-
integration of both transgenes into a single genomic site, we
performed PCR analysis with primers designed to amplify the
region between the eye marker and its neighboring transgene. In
all five transgenic lines tested, the PCR product was present in
transgenic animals but not wildtype littermates (Fig. 3B and Fig.
S1). These results confirm that the fluorescent eye markers co-
integrate with the unrelated transgenes into the same transgene
concatamer.
To determine if the fluorescent eye markers affect the
expression patterns of the co-injected transgene, we performed
immunofluorescent staining in several lines where the EGFP
marker was co-injected with a conditional transposase (PBaseER)
for the PB transposon. PBaseER expression in these lines was
restricted as expected to the epidermis and hair follicle by the
human keratin 14 promoter [19] or the mouse P-cadherin
promoter [20] (Fig. S2). When crossed with mice carrying a
mutagenic piggyBac transposon, the double transgenic animals
develop skin tumors providing further evidence that the expression
and function of the co-injected transgenes are not affected by the
eye markers [14]. Importantly, we did not observe ectopic
expression of the EGFP fluorescent eye markers in the skin in
these lines (Fig. S2). Thus, the fluorescent eye markers are
specifically expressed and do not affect the proper expression and
behavior of the co-injected transgenes.
Figure 1. Expression of aA-crystallin driven fluorescent proteins in a-TN4 mouse lens epithelial cells. (A) Schematic map of aA-crystallin
fluorescent protein constructs drawn to scale. Features include the 2.5 kb aA-crystallin promoter and the 1 kb fluorescent protein coding sequence
and polyadenylation signal (1.6 kb for tdTomato). (B) Fluorescent protein expression 48 hours post-transfection. Images were taken in grayscale and
pseudo color added using AxioVision digital image processing software.
doi:10.1371/journal.pone.0029486.g001
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correlates with gene dosage. We self-crossed mice that were
heterozygous for mCFP, tdTomato or EGFP eye markers and
analyzed marker fluorescent intensity in their offspring. Both adult
(Fig. 4A) and neonatal (Fig. 4C) offspring could be separated as
heterozygous or homozygous for the marker by visualizing
fluorescence intensity under a portable flashlight. We could also
use whole animal in vivo fluorescence microscopy to identify
homozygous from heterozygous transgenic mice (Fig. 4B). When
these homozygous animals were crossed to wildtype FVB/NJ
mice, all offspring carried the marker transgene as expected.
Ketamine-xylazine anesthesia is frequently used in animal
manipulations and can cause acute reversible cataracts in mice
[21]. We found that marker fluorescence intensity increased with
acute cataract formation (Fig. S3). Taken together, these
fluorescent eye markers make it possible to quickly and accurately
identify homozygous transgenic mice.
Finally, we asked if the fluorescent eye markers could be used to
distinguish mice that carry more than one transgene. To address
this question, we sat up matings between transgenic mice with
different color eye markers. We evaluated eight different two
marker combinations in all. Indeed, in seven of the eight
Figure 2. Fluorescent eye marker visibility and variability. (A) Fluorescent proteins expressed in the lens can be visualized under a handheld
flashlight. All five fluorescent eye markers can be seen using the GFP flashlight while only mOrange, tdTomato, and mPlum can be seen using the RFP
flashlight. (B) EGFP and tdTomato marker expression varies between transgenic lines (Low, Medium, High). Inset shows EGFP ‘‘high’’ line is visible in
room light with no excitation. EGFP ‘‘medium’’ and tdTomato ‘‘high’’ transgenic lines are also shown in pigmented (Agouti, Black) backgrounds. Note
that the visibility of fluorescent eye markers is reduced in pigmented backgrounds.
doi:10.1371/journal.pone.0029486.g002
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from mice carrying a single transgene by visualizing fluorescent
markers in the eye (Fig. 5 and Table S1). For example, EGFP and
tdTomato double transgenic animals could be distinguished by a
yellow eye color while the single transgenic eyes appear green and
red respectively (Fig. 5A). We also found that the triple marker
combination of mCFP, mOrange and mPlum could be used to
identify and differentiate triple transgenic animals (Fig. 5B). Thus,
the different fluorescent eye markers can be used to distinguish
mice carrying up to three different transgenes without the need for
PCR genotyping.
Discussion
In summary, we developed and characterized a set of broadly
useful fluorescent eye markers that allows for the rapid and easy
detection of transgenic mice. We demonstrated that these eye
markers can be used to visibly follow the segregation of transgenes
from one generation to the next using a handheld flashlight. This
method is non-invasive and eliminates the need to subject
transgenic animals to the stress of isolating tissue for genomic
DNA extraction and genotyping. Moreover, visual identification of
eye markers can be performed from postnatal day one to adult
while tissue sample removal is limited to a short window of time.
In addition, we showed that marker fluorescent intensity correlates
to transgene dosage allowing for quick identification of homozy-
gous transgenic animals. We were also able to easily distinguish
single, double and triple transgenic mice by marking different
transgenes with unique color eye markers. Analysis of animals with
multiple transgenes or genetic alterations is routinely done in
invertebrate model organisms but has been difficult for mammals.
The ability to differentiate mice with multiple genetic alterations
will greatly facilitate analysis of epistasis and other genetic
interactions. Although we limited our analysis to transgenic
animals in the present study, these fluorescent eye markers could
potentially be incorporated into gene targeting constructs for
knockout studies. In addition, as the crystallin promoter is highly
conserved in vertebrates, these eye markers could also be used for
genetic studies in other mammalian model systems. The
fluorescent eye marker system described here is widely applicable
for mammalian transgenic work, not only reducing both the
resources and the time traditionally required, but also further
empowering genetic analysis.
Materials and Methods
Ethics Statement
All experiments were approved by and conducted in compli-
ance with the Yale Animal Resources Center and the Institutional
Animal Care and Use Committee under protocol number 2008-
10230.
Construction of transgenic constructs
The aA-crystallin-EGFP plasmid, pA425, was described
previously [9]. Coding sequences for EBFP (Clonetech),
mCFP[12] and mPlum[13] were PCR amplified using primers
that contained a BamHI recognition site on the 59 and EcoRI
recognition site on the 39. All other fluorescent protein coding
sequences were released from the pRSET-B vector by digestion
with BamHI and EcoRI. All fluorescent protein coding sequences
were then cloned into the BamHI/EcoRI sites in pEF6/V5-His
(Invitrogen). Finally, they were released from pEF6/V5-His by
BamHI/NotI digestion and cloned into pA425 to replace the
EGFP coding sequence. All fluorescent marker constructs will be
available upon request.
Cell Culture, transfections and imaging
Mouse lens epithelial a-TN4 cells were cultured in Dulbecco’s
modified Eagle’s medium containing 10% fetal bovine serum,
100 mg/ml penicillin and 100 mg/ml streptomycin in a humidified
5% CO2 atmosphere. Cells in 24-well plates were transfected with
0.8 mg plasmid DNA using 2 mg Lipofectamine 2000 (Invitrogen).
Figure 3. Co-segregation and co-integration of fluorescent eye marker and transgene. (A) tdTomato fluorescent eye marker co-
segregates with and accurately marks the presence of an unrelated transgene (Luc-PB[mut]7). One litter of pups numbered 1-7 is shown. The
unrelated transgene was amplified by PCR (upper panel) and the tdTomato marker was visualized under the GFP flashlight in room light (lower
panel). (B) Schematic drawing of PCR strategy. One PCR primer (small arrows) was designed against the 39 end of the Luc-PB[mut]7 transgene (gray
box) and the other primer against the aA-crystallin promoter (white box) driving the tdTomato marker transgene. (C) The hybrid PCR product from
the transgene concatamer is present in two transgenic animals (+) but not wildtype littermates (2).
doi:10.1371/journal.pone.0029486.g003
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inverted fluorescent microscope (Carl Zeiss).
Generation of transgenic mice
All transgenic mice were generated at the Yale University
Transgenic Mouse Core Facility. Transgenic mice were produced
by microinjecting the purified MluI and AflII fragment of aA-
crystallin marker constructs with linearized unrelated transgenes at
a ratio of 1:3 into FVB/NJ or (C57BL/6J X SJL/J) F2 fertilized
eggs. Transgenic founders were identified by PCR genotyping of
genomic DNA with forward primer A-CRY (59-GCTCCTG-
TCTGACTCACTGC-39) and reverse primers FP-R2 (59-G-
GAATTCTTACTTGTACAGCTCGTCCATG-39) or MPLUM-
R( 5 9-CGGAATTCTTAGGCGCCGGTGGAGTGG-39) for aA-
cry-mPlum. Founders were mated with FVB/NJ mice to establish
transgenic lines.
PCR
Luc-PB[mut]7 transgenic mice were genotyped by PCR genotyping
of genomic DNA with forward primer LucPBLF (59 TGAATAC-
GATTTTGTGCCAG 39) and reverse primer LucR (59GGATCCT-
TATCGATTTTACC 39) yielding the expected product size of 1.4 kb.
For detection of hybrid PCR products spanning the junctions between
the eye markers and transgenes of interest in transgenic concatamers,
the following primers were used: PBase39-F (59 ACATATGG-
GAGGGCAAATCA 39), Cry promoter-R (59 AGCCTGGAAGTA-
GACCAGCA 39), EGFP pA-R (59 CCCCCTGAACCTGAAA-
CATA 39), Pcad Promoter-R (59 TCTGGCACCCCCAATATAAA
39), and Luc39-F1 (59 CGTCGCCAGTCAAGTAACAA 39).
In vivo imaging of fluorescent eye markers
For fluorescent photographs, mice were anesthetized using
ketamine/xylazine (100mg/kg, 10mg/kg) and marker fluores-
Figure 4. The intensity of the fluorescent eye markers allows differentiation of heterozygous from homozygous transgenic mice.
(A) Heterozygous and homozygous adult mice carrying mCFP or tdTomato markers can be easily identified under a handheld flashlight.
(B) Homozygosity in adult mice can also be determined more quantitatively using whole animal in vivo fluorescence imaging. (C) Neonatal mice
carrying EGFP or tdTomato markers can also be easily identified as heterozygous or homozygous under a handheld flashlight. (* marks heterozygous
animals, # marks homozygous animals)
doi:10.1371/journal.pone.0029486.g004
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DFP-1 Dual Fluorescent Protein flashlight (Nightsea). Photo-
graphs of fluorescent eye markers were taken using an Eos Rebel
XTi digital camera (Canon) using the following exposure settings:
ISO 1600, 1/100 second, f 5.6. The camera was fitted with
appropriate 58mm lens filters to block the emission light. For
GFP we used the BB58 barrier filter (Nightsea) and for RFP we
used a Red 25 filter (Tiffen). For in vivo fluorescent microscopy,
mice were anesthetized with isoflurane using the XGI-8 gas
anesthesia system and imaged using an IVIS Spectrum (Xenogen
Corporation-Caliper Life Sciences). Epi-fluorescent images were
taken using different combinations of filter sets and light outputs
were quantified using Living Image software (Caliper Life
Sciences). Images were processed using Adobe Photoshop
software.
Immunofluorescence of frozen skin sections
Mouse backskin was immediately embedded in OCT, frozen,
and sectioned. Sections were fixed for 10 min in 4% PFA in PBS,
washed three times for 5 min in PBS, and permeabilized in 0.1%
Triton for 15 minutes at RT. Sections were then washed three
times for 5 min in PBS and blocked for 1 hour at RT in a
humidified chamber using the following blocking solution: 5%
NGS, 1% BSA in 0.1% Triton X in PBS. Primary antibody
staining against the estrogen receptor (ERa) was done overnight at
4
o using rabbit polyclonal ERa anitibody (MC-20:sc-542,1:100,
Santa Cruz Biotechnology). DAPI (1:3000) was used for nuclear
staining. Stained slides were imaged using the Axio Observer.A1
inverted fluorescent microscope (Carl Zeiss).
Supporting Information
Figure S1 Co-integration of fluorescent eye markers with
PBaseER transgenes. (A) Schematic drawing of PCR strategy for
K14-PBaseER and Act-PBaseER transgenic lines (on left). One
PCR primer (small arrows) was designed against the 39 end of the
PBaseER transgene (gray box) and the other primer against the 39
end of the EGFP marker transgene (green box). The hybrid PCR
product from the transgene concatamer is present in transgenic
animals (+) but not wildtype littermates (-). (B) Schematic drawing
of PCR strategy for LSL-PBaseER and Pcad-PBaseER transgenic
lines (on left). One PCR primer (small arrows) was designed
against the 39 end of the PBaseER transgene (gray box) and the
other primer against the aA-crystallin promoter (white box)
driving the EGFP marker transgene (white box). The hybrid PCR
product from the transgene concatamer is present in transgenic
animals (+) but not wildtype littermates (-).
(TIF)
Figure 5. Fluorescent eye markers allow visual identification of double and triple transgenic mice. (A) Double transgenic mice carrying
the EGFP marker and either tdTomato or mPlum can be easily distinguished from single transgenic littermates under the GFP flashlight. (B) Single,
double and triple transgenic mice can be identified using mCFP, mOrange and mPlum eye markers. All six possible combinations are distinguishable
under the GFP flashlight. Insets show close up view of fluorescence in the eyes of double and triple transgenic mice.
doi:10.1371/journal.pone.0029486.g005
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fluorescent eye markers. Immunofluorescent staining of frozen skin
sections from (A) WT, (B) K14-PBaseER (3 independent lines),
and (C) Pcad-PBaseER (1 line) shows expression as expected in
the epidermis and hair follicles. Note that ectopic fluorescence
from the eye markers was not observed.
(TIF)
Figure S3 Anesthesia-induced acute cataracts affect fluorescent
eye marker intensity. (A) Heterozygous and homozygous adult
mice carrying tdTomato markers can be easily identified under a
handheld flashlight. Mice imaged quickly have not developed
cataracts. (B) tdTomato marker intensity increases following acute
cataract formation (inset). Mice were imaged following ten minutes
of anesthesia.
(TIF)
Table S1 Fluorescent eye marker combinations.
(DOC)
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